Literature DB >> 1360090

Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA.

W Reardon1, R J Ross, M G Sweeney, L M Luxon, M E Pembrey, A E Harding, R C Trembath.   

Abstract

Family studies of diabetes mellitus (DM) show that patients are more likely to have affected mothers than affected fathers. Since the inheritance of mitochondrial (mtDNA), unlike nuclear DNA, is exclusively maternal, could it be that defect(s) in mtDNA account for some cases of DM? Such defects have been associated with rare neurological syndromes, in some of which DM has been an accompanying feature. We have looked for glucose intolerance and for a previously known point mutation of mtDNA in a family, some of whose members have a multisystem disorder with DM but not neurological involvement. DNA samples were obtained from fourteen family members. The point mutation (affecting position 3243 in the tRNA leucine mitochondrial gene) was found in all three diabetic patients and post mortem tissues in the proband; it was also found in seven offspring of female patients. It was not found in the two children of the male proband. The contribution of this mutation to DM in general is not known but clinicians ought to be aware of the possibility, especially in families with multisystem disease and maternal transmission.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1360090     DOI: 10.1016/0140-6736(92)92560-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  75 in total

Review 1.  Clinical mitochondrial genetics.

Authors:  P F Chinnery; N Howell; R M Andrews; D M Turnbull
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

Review 2.  Mitochondria.

Authors:  P F Chinnery; E A Schon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

Review 3.  The genetics of strabismus.

Authors:  M Michaelides; A T Moore
Journal:  J Med Genet       Date:  2004-09       Impact factor: 6.318

4.  Prevalence of mitochondrial gene mutations among hearing impaired patients.

Authors:  S Usami; S Abe; J Akita; A Namba; H Shinkawa; M Ishii; S Iwasaki; T Hoshino; J Ito; K Doi; T Kubo; T Nakagawa; S Komiyama; T Tono; S Komune
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

5.  Sequence polymorphisms of the mtDNA control region in a human isolate: the Georgians from Swanetia.

Authors:  Miguel A Alfonso-Sánchez; Cristina Martínez-Bouzas; Azucena Castro; Jose A Peña; Isabel Fernández-Fernández; Rene J Herrera; Marian M de Pancorbo
Journal:  J Hum Genet       Date:  2006-04-01       Impact factor: 3.172

6.  Point mutation of the mitochondrial tRNA(Leu) gene (A 3243 G) in maternally inherited hypertrophic cardiomyopathy, diabetes mellitus, renal failure, and sensorineural deafness.

Authors:  S Manouvrier; A Rötig; G Hannebique; J D Gheerbrandt; G Royer-Legrain; A Munnich; M Parent; J P Grünfeld; C Largilliere; A Lombes
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

7.  Mitochondrial Respiratory Disorders: A Perspective on their Metabolite Biomarkers and Implications for Clinical Diagnosis and Therapeutic Intervention.

Authors:  Martine Uittenbogaard; Anne Chiaramello
Journal:  Biomark J       Date:  2015-10-12

8.  A novel class of tests for the detection of mitochondrial DNA-mutation involvement in diseases.

Authors:  Fengzhu Sun; Jing Cui; Haralambos Gavras; Faina Schwartz
Journal:  Am J Hum Genet       Date:  2003-04-30       Impact factor: 11.025

9.  Difference in the influence of maternal and paternal NIDDM on pancreatic beta-cell activity and blood lipids in normoglycaemic non-diabetic adult offspring.

Authors:  T Kasperska-Czyzyk; K Jedynasty; R R Bowsher; D L Holloway; I Stradowska; K Stepień; R Nowaczyk; W Szymczak; A Czyzyk
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

10.  Is there an excess in maternal transmission of NIDDM?

Authors:  B D Mitchell; C M Kammerer; L J Reinhart; M P Stern; J W MacCluer
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.